Status:

ACTIVE_NOT_RECRUITING

[18F]ISO-1 Positron Emission Tomography (PET/CT) in Primary Breast Cancer

Lead Sponsor:

University of Pennsylvania

Conditions:

Breast Cancer

Breast Neoplasm

Eligibility:

FEMALE

18+ years

Phase:

PHASE1

Brief Summary

In this study, positron emission tomography (PET/CT) imaging will be used to evaluate sigma-2 (σ2) receptor activity in sites of primary breast cancer using the investigational radiotracer \[18F\]ISO-...

Detailed Description

This study will evaluate the feasibility of using \[18F\]ISO-1 PET/CT to image sigma-2 receptor binding in primary breast tumors and continue to evaluate the safety of the tracer in this patient popul...

Eligibility Criteria

Inclusion

  • Adult patients, at least 18 years of age
  • Known or suspected breast cancer with at least one breast lesion that is 1 cm or greater in size by standard imaging (e.g. mammography, ultrasound or breast MRI)
  • Participants must be informed of the investigational nature of this study and provide written informed consent in accordance with institutional and federal guidelines prior to study-specific procedures

Exclusion

  • Females who are pregnant at the time of screening will not be eligible for this study, urine or serum pregnancy test will be performed in women of child-bearing potential at the time of screening.
  • Inability to tolerate imaging procedure in the opinion of an investigator or treating physician
  • Serious or unstable medical or psychological conditions that, in the opinion of the investigator, would compromise the subject's safety or successful participation in the study.
  • Unwilling or unable to provide informed consent.

Key Trial Info

Start Date :

March 11 2015

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 1 2026

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT02284919

Start Date

March 11 2015

End Date

November 1 2026

Last Update

January 9 2026

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Pennsylvania Hospital

Philadelphia, Pennsylvania, United States, 19104

[18F]ISO-1 Positron Emission Tomography (PET/CT) in Primary Breast Cancer | DecenTrialz